DanCann Pharma A/S publishes Annual Report 2020

Report this content

COPENHAGEN, Denmark, 07 April 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) announce that The Board of Directors and the Chief Executive Officer of DanCann Pharma hereby publishes the annual report of the year 2020. The annual report including the auditor’s report is available in this press release and on the website of DanCann Pharma.

For more information, visit: https://www.dancann.com/investor-relations-ir/general-meetings.  


About DanCann Pharma

DanCann Pharma A/S (SS: DANCAN) was founded in 2018 and is a Danish biopharmaceutical company powered by cannabinoids. DanCann Pharma is a vertically integrated, licensed production and distribution company based in Denmark. The company focuses on discovering, developing, manufacturing, and commercializing new therapeutic cannabinoids in a wide range of disease areas.

For further information, please contact:

Jeppe Krog Rasmussen, CEO
Website: www.dancann.com